The arginine metabolome in acute lymphoblastic leukemia can be targeted by the pegylated‐recombinant arginase I BCT‐100

E-ISSN： 1097-0215|142|7|1490-1502

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.7, 2018-04, pp. : 1490-1502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of methotrexate, vincristine, pegylated‐asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 2, 2015-02 ,pp. : 120-124

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 3, 2018-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualized therapy for childhood acute lymphoblastic leukemia

By Raetz Elizabeth A Bhojwani Deepa Min Dong-Joon Carroll William L

Personalized Medicine, Vol. 2, Iss. 4, 2005-11 ,pp. : 349-361

Future Medicine

Access to resources Recommend Favorite

Recent progress in the treatment of infant acute lymphoblastic leukemia

PEDIATRICS INTERNATIONAL, Vol. 57, Iss. 5, 2015-10 ,pp. : 811-819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Lymphoblastic Leukemia in a Patient with Chronic Cyanoacrylate Exposure

Acta Haematologica, Vol. 118, Iss. 4, 2007-12 ,pp. : 242-243

Karger

Access to resources Recommend Favorite